Polpharma CDMO

Polpharma is leading multinational pharmaceutical group trusted by millions of patients and business partners for over 85 years. Thanks to over 70 years of experience in process development, scale-up and cGMP manufacturing, we support both emerging and established pharmaceutical customers in development and commercialization of their small molecule API clinical candidates. At our FDA-approved plant located in Central Europe we provide end-to-end solutions from non-GMP intermediates to API, from route scouting to development and validation at commercial scale, supporting clients from early stage clinical trials supplies to full life cycle management. Our R&D and chemical engineering teams are highly experienced in development of complex chemical processes and, supported by a wide range of assets, including cryogenic, High Pressure, strong base reactions and tailor-made particle size distribution modifications, high containment… can provide customized solutions to our customers. For drug products, Polpharma provides also customized contract manufacturing service, technological transfer and full analytical support. Our team of highly qualified, skilled and enthusiastic experts combined with state-of-the-art equipment and facilities provides our partners with an outstanding customer experience. Polpharma CDMO, your European fully integrated CDMO Partner.

Witryna

http://cdmo.polpharma.com/

Link zewnętrzny organizacji Polpharma CDMO

Branża

Produkcja wyrobów farmaceutycznych

Wielkość firmy

1 001-5 000 pracowników

Siedziba główna

Starogard Gdański, Pomorskie